Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay

BACKGROUND: The coronavirus disease 2019 (COVID-19) endgame may benefit from simple, accurate antibody testing to characterize seroprevalence and immunization coverage. OBJECTIVES: To evaluate the performance of the lateral flow QIAreach anti-SARS-CoV-2 Total rapid nanoparticle fluorescence immunoas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Virol
Main Authors: Sibai, Mamdouh, Solis, Daniel, Röltgen, Katharina, Stevens, Bryan A., Mfuh, Kenji O., Sahoo, Malaya K., Shi, Run Z., Zehnder, James, Boyd, Scott D., Pinsky, Benjamin A.
Formato: Artigo
Idioma:Inglês
Publicado em: Published by Elsevier B.V. 2021
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8015349/
https://ncbi.nlm.nih.gov/pubmed/33932848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2021.104818
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados